i+Med S. Coop.

About i+Med S. Coop.

i+Med is a leading pharmaceutical company dedicated to the development, manufacture and commercialisation of injectables, eye drops and topical products for the therapeutic areas of traumatology, aesthetics, ophthalmology and dermatology


 We are world experts in hydrogels and smart nanohydrogels technologies. Under our controlled release technologies patents we develop innovative formulas and products for third parties. A more than 100 people unique Cooperative of scientists.

Certifications
  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from i+Med S. Coop. (5)

  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • TrHCROSS - Joint injections (cross-linked HA 2%)

    Product TrHCROSS - Joint injections (cross-linked HA 2%)

    TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

    Properties
    ...
  • BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    Product BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    BtHCROSS is a biocompatible cross-linked hyaluronic acid hydrogel intended as a dermatological treatment for aesthetic purposes. It is administered by intradermal injection and designed to restore and correct facial volumes and fill wrinkles and folds.
    Depending on the depth of the wrinkles an...
  • DayDrop - eye drops with the sustained-release system of ectoine

    Product DayDrop - eye drops with the sustained-release system of ectoine

    DayDrop is an ophthalmic solution with sustained release of ectoine, indicated to alleviate the ocular dryness and irritation produced by environmental factors (wind, dust, air conditioning, dry heat), prolonged use of screens or contact lenses and some pathologies that present the above mentioned symp...

i+Med S. Coop. Resources (1)

  • Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...